Features of GBA-associated Parkinson's disease at presentation in the United Kingdom Tracking Parkinson's study

被引:0
作者
Malek, Naveed [1 ]
Weil, Rimona [2 ]
Bresner, Catherine [3 ]
Lawton, Michael [4 ]
Grosset, Katherine [5 ]
Tan, Manuela [2 ]
Bajaj, Nin [6 ]
Barker, Roger [7 ]
Burn, David [8 ]
Foltynie, Thomas [9 ]
Hardy, John [10 ]
Wood, Nicholas [11 ]
Ben-Shlomo, Yoav [4 ]
Williams, Nigel [3 ]
Grosset, Donald [5 ]
Morris, Huw [2 ]
机构
[1] Ipswich Hosp NHS Trust, Dept Neurol, Ipswich, Suffolk, England
[2] UCL Inst Neurol, Dept Mol Neurosci, London, England
[3] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales
[4] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[5] Queen Elizabeth Univ Hosp, Inst Neurosci, Dept Neurol, Glasgow, Lanark, Scotland
[6] Queens Med Ctr, Dept Neurol, Nottingham, England
[7] Addenbrookes Hosp, Dept Neurol, Cambridge, England
[8] Royal Victoria Infirm, Dept Neurol, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England
[9] UCL Inst Neurol, Sobell Dept Motor Neurosci, London, England
[10] UCL Inst Neurol, Reta Lila Weston Labs, Dept Mol Neurosci, London, England
[11] Natl Hosp Neurol & Neurosurg, Dept Neurogenet, London, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S3.003
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Cardiovascular autonomic function in GBA-associated Parkinson's disease: a cross-sectional study
    De Santis, T.
    Cocco, A.
    Polverino, P.
    Polvere, V.
    Valente, E. M.
    Albanese, A.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S472 - S472
  • [22] Involvement of the genes related to lysosomal storage disorders in GBA-associated Parkinson's disease
    Bezrukova, A.
    Bogdanova, D.
    Basharova, K.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Pchelina, S.
    Usenko, T.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S1 - S2
  • [23] Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients
    Slingerland, Sofie
    van der Zee, Sygrid
    Carli, Giulia
    Slomp, Anne C.
    Boertien, Jeffrey M.
    d'Angremont, Emile
    Bohnen, Nicolaas, I
    Albin, Roger L.
    van Laar, Teus
    [J]. BRAIN, 2024, 147 (03) : 900 - 910
  • [24] Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk
    Straniero, Letizia
    Rimoldi, Valeria
    Monfrini, Edoardo
    Bonvegna, Salvatore
    Melistaccio, Giada
    Lake, Julie
    Solda, Giulia
    Aureli, Massimo
    Shankaracharya
    Keagle, Pamela
    Foroud, Tatiana
    Landers, John E.
    Blauwendraat, Cornelis
    Zecchinelli, Anna
    Cilia, Roberto
    Di Fonzo, Alessio
    Pezzoli, Gianni
    Duga, Stefano
    Asselta, Rosanna
    [J]. MOVEMENT DISORDERS, 2022, 37 (06) : 1202 - 1210
  • [25] GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
    Brockmann, Kathrin
    Srulijes, Karin
    Pflederer, Sylvia
    Hauser, Ann-Kathrin
    Schulte, Claudia
    Maetzler, Walter
    Gasser, Thomas
    Berg, Daniela
    [J]. MOVEMENT DISORDERS, 2015, 30 (03) : 407 - 411
  • [26] iPSC-derived in vitro striatal circuits to understand GBA-associated Parkinson's disease
    Do, Quyen
    Ng, Bryan
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    [J]. JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 96 - 97
  • [27] Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
    Emelyanov, A. K.
    Baydakova, G. V.
    Andoskin, P. A.
    Nikolaev, M. A.
    Senkevich, K. A.
    Milyukhina, I. V.
    Yakimovskii, A. F.
    Timofeeva, A. A.
    Fedotova, E. Y.
    Nuzhnyi, E. P.
    Illarioshkin, S. N.
    Zakharova, E. Y.
    Pchelina, S. N.
    [J]. MOVEMENT DISORDERS, 2016, 31 : S214 - S215
  • [28] Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson's disease
    Kopytova, A.
    Nikolaev, M.
    Senkevich, K.
    Baydakova, G.
    Miliukhina, I.
    Zakharova, E.
    Pchelina, S.
    [J]. MOVEMENT DISORDERS, 2019, 34
  • [29] Contribution of the SNCA gene and genes involved in autophagy in the pathogenesis of GBA-associated parkinson's disease
    Basharova, K.
    Bezrukova, A.
    Bogdanova, D.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Emelyanov, A.
    Pchelina, S.
    Usenko, T.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S11 - S11
  • [30] Structural MRI features of glucocerebrosidase (GBA)-associated Parkinson's disease
    Patel, R.
    Stoub, T.
    Cozzi, B.
    Pal, G.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S572 - S573